# A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

> **NCT03187301** · PHASE2 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Parkinson's Disease
- Off Episodes of Parkinson Disease

## Interventions

- **DRUG:** APL-130277
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT03187301
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-03
- **Primary completion:** 2017-12-21
- **Final completion:** 2017-12-21
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187301, "A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03187301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*